Gambia vs Rwanda: Cause of death, by non-communicable diseases, ages 5-14, female
Gambia
25.2%
in 2021
Rwanda
24.8%
in 2021
Gambia rank
140th
Rwanda rank
143rd
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Gambia
- Rwanda
How they compare
Gambia currently reports 25.2% against 24.8% in Rwanda, a difference of 0.4%.
Across all 6 years both countries report, Gambia has been ahead every year.
Gambia ranks 140th and Rwanda ranks 143rd of 184 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.2% | 18.0% | 1.2% | Gambia |
| 2010s | 24.3% | 20.9% | 3.4% | Gambia |
| 2020s | 25.2% | 24.8% | 0.5% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Gambia or Rwanda?
- Gambia, at 25.2% against 24.8% in Rwanda as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Gambia and Rwanda?
- 0.4%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Rwanda?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Rwanda rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Gambia ranks 140th and Rwanda ranks 143rd of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.